RÉSUMÉ
The dried roots of Angelica sinensis has been widely applied in clinical care due to its efficiencies in nourishing and activating blood, regulating female menstrual disorders and relieving pains, relaxing bowels, etc. The cultivated two-year-old plants normally harvested roots for medicinal uses emerge over 30% early bolting rate, which leads to the lignified roots that are useless in medicinal agents. The early bolting and flowering that are leading to serious yield reduction has been one of the most serious problems in the production of A. sinensis for many years. Here, based on previously published research articles, monographs, patents as well as practice experiences, the research progresses on the internal and external factors affecting bolting and flowering of A. sinensis, the pathways regulating bolting and flowering, the mechanism revealing bolting and flowering by biotechnological interventions were summarized, with the aim of providing effective pathways jointly internal and external factors for regulating bolting and flowering, as well as references for further revealing the mechanism of the bolting and flowering of A. sinensis.
RÉSUMÉ
[Aim] The expressed system of sterol regulation by SCAP/SREBP Pathway was established in the oocyte of the Xenopus laevis and was applied to investigate the effect of cucurmin on the SREBP pathway.[Methods] The plasmid of PLXRN-4SRE-fpa was restructed and injected into the nucleus of Xenopus Oocytes in phase V or VI. The oocyte was incubated with different concentrations of the curcumin. After three days the fluorescence intensity on the membrane of the Oocytes was measured by Fluoroanalyzer.[Results] The fluoresecence intensity on the membrane of the oocyte increased with increasing of the concentration of the curcumin. The trail group which have all regulation elements of SCAP/SREBP pathway can express more fluorscence protein than the control group. [Conclusion] The experiment provides that the curcumin can upgrade the expression of low density lipoprotein receptor by SCAP/SREBP regulation pathway. The model can be applied for quick screening of the scap ligand drugs and inverstigating the mechanism of the drugs.